A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy
Clinical trial NCT04656561 · COMPLETED
Trial details
- NCT number
- NCT04656561
- Sponsor
- Annexon, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-26
- Primary completion
- 2023-03-28
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.